Immucell (ICCC) EBITDA Margin (2009 - 2026)
Immucell (ICCC) posted EBITDA Margin of 17.66% for Q3 2026, up 3.81 percentage points from 13.86% a year earlier but down 15.85 percentage points from the prior quarter.
Immucell (ICCC) EBITDA Margin (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, EBITDA Margin at Immucell was 21.06%, up 2.44 percentage points year-over-year; for FY2025, it came in at 16.30%, up 11.96 percentage points from FY2024.
- Annual EBITDA Margin shows a five-year change of +9.21 percentage points (FY2020 to FY2025).
- In prior years, Immucell's EBITDA Margin was 4.35% in FY2024 (+21.33 pp), -16.98% in FY2023 (-18.18 pp), 1.20% in FY2022 (-13.11 pp) and 14.31% in FY2021 (+7.21 pp).
- Quarterly EBITDA Margin has run from a low of -46.15% in Q1 2023 to a high of 33.52% in Q2 2026 over five years.
- On a year-over-year basis, EBITDA Margin has increased in each of the last three quarters, with an average year-over-year change of +10.29 percentage points over the last seven quarters.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q1 2024, with a gain of 51.56 percentage points; the weakest was Q1 2023, with a drop of 66.16 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was 33.52% (Q2 2026), 24.18% (Q1 2026) and 8.65% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 42.49% |
| 10 | Immucell | 102.43 Mn | 75.03 Mn | 3.56 Mn | 17.66% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 17.66% |
| Jun 30, 2026 | 33.52% |
| Mar 31, 2026 | 24.18% |
| Dec 31, 2025 | 8.65% |
| Sep 30, 2025 | 13.86% |
| Jun 30, 2025 | 19.62% |
| Mar 31, 2025 | 22.56% |
| Dec 31, 2024 | 17.05% |
| Sep 30, 2024 | 2.11% |
| Jun 30, 2024 | -12.59% |
| Mar 31, 2024 | 5.41% |
| Sep 30, 2023 | -8.55% |
| Jun 30, 2023 | -17.30% |
| Mar 31, 2023 | -46.15% |
| Dec 31, 2022 | -26.10% |
| Sep 30, 2022 | 0.50% |
| Jun 30, 2022 | 0.49% |
| Mar 31, 2022 | 20.01% |
| Dec 31, 2021 | 13.84% |
| Sep 30, 2021 | 17.40% |
Immucell EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ICCC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();